TXMD (STOCKS)
TherapeuticsMD, Inc.
$2.280000
+0.080000 (+3.64%)
Prev close: $2.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Marlan D. Walker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $26.51M
- Employees
- 1
- P/E (TTM)
- 142.86
- P/B (TTM)
- 0.94
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2023 (Q3)
|
$-0.13 | $-0.05 | -0.0790 | -154.90% |
|
Jun 2023 (Q2)
|
$-0.24 | $-0.07 | -0.1686 | -236.13% |
|
Mar 2023 (Q1)
|
$-0.37 | $0.06 | -0.4312 | -704.58% |
|
Dec 2022 (Q4)
|
$8.23 | $-1.13 | +9.3622 | +826.90% |
Financial Statements
| Revenues | $3.35M |
| Benefits Costs and Expenses | $3.24M |
| Costs And Expenses | $3.24M |
| Nonoperating Income/Loss | $3.95M |
| Operating Expenses | $7.19M |
| Depreciation and Amortization | $383.00K |
| Other Operating Expenses | $6.80M |
| Operating Income/Loss | -$3.83M |
| Income/Loss From Continuing Operations After Tax | $86.00K |
| Income/Loss From Continuing Operations Before Tax | $118.00K |
| Income/Loss From Discontinued Operations Net Of Tax | $93.00K |
| Net Income/Loss | $179.00K |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $179.00K |
| Net Income/Loss Available To Common Stockholders, Basic | $179.00K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.02 |
| Diluted Earnings Per Share | $0.02 |
| Basic Average Shares | 23,161,574 |
| Diluted Average Shares | 23,161,640 |
| Assets | $37.58M |
| Current Assets | $15.26M |
| Noncurrent Assets | $22.32M |
| Intangible Assets | $3.67M |
| Other Non-current Assets | $18.65M |
| Liabilities | $10.61M |
| Current Liabilities | $4.91M |
| Accounts Payable | $15.00K |
| Wages | $379.00K |
| Other Current Liabilities | $4.52M |
| Noncurrent Liabilities | $5.70M |
| Equity | $26.97M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $26.97M |
| Liabilities And Equity | $37.58M |
| Net Cash Flow From Operating Activities | $2.67M |
| Net Cash Flow From Operating Activities, Continuing | $2.70M |
| Net Cash Flow From Operating Activities, Discontinued | -$25.00K |
| Net Cash Flow | $2.67M |
| Net Cash Flow, Continuing | $2.70M |
| Net Cash Flow, Discontinued | -$25.00K |
| Comprehensive Income/Loss | $179.00K |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $179.00K |
| Other Comprehensive Income/Loss | $0.00 |